ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.
BACKGROUND
To present a summary of the 2nd International Consultation on Bladder Cancer recommendations on the pathology of bladder cancer using an evidence-based strategy.


OBJECTIVE
To standardize descriptions of the diagnosis and reporting of urothelial carcinoma of the bladder and help optimize uniformity between individual pathology practices and institutions.


METHODS
A detailed Medline analysis was performed for original articles addressing bladder cancer with regard to pathology. Proceedings from the last 5 yr of major conferences were also searched.


RESULTS
The major findings are presented in an evidence-based fashion. Large retrospective and prospective data were analyzed.


CONCLUSIONS
Providing the best management for patients with bladder neoplasia relies on close cooperation and teamwork among urologists, oncologists, radiologists, and pathologists.
Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Mahul.Amin@cshs.org
Mahul B
MB
Amin
Jesse K
JK
McKenney
Gladell P
GP
Paner
Donna E
DE
Hansel
David J
DJ
Grignon
Rodolfo
R
Montironi
Oscar
O
Lin
Merce
M
Jorda
Lawrence C
LC
Jenkins
Mark
M
Soloway
Jonathan I
JI
Epstein
Victor E
VE
Reuter
D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D001706:Biopsy / Q000592:standards; D002277:Carcinoma / Q000737:chemistry / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D003299:Cooperative Behavior; D006801:Humans; D007150:Immunohistochemistry / Q000592:standards; D033183:Interdisciplinary Communication; D009367:Neoplasm Staging / Q000592:standards; D010338:Pathology, Clinical / Q000592:standards*; D057089:Pathology, Molecular / Q000592:standards*; D011237:Predictive Value of Tests; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D019459:Urothelium / Q000737:chemistry / Q000473:pathology*
D014408:Biomarkers, Tumor